Archives: 2018

MJFF Webinar: Parkinson’s Will Double by 2040: Are We Ready?

post

Scientists predict the number of people with Parkinson’s in the world will double by 2042 to more than 12 million. In this webinar, our expert panelists will review some reasons behind the growth and strategies for addressing the “Parkinson’s Pandemic.”

Title: Parkinson’s Will Double by 2040: Are We Ready?

Date: Thursday, March 15, 2018

Time: 12 p.m. ET

Duration: 1 hour

To register and get more information:

https://www.michaeljfox.org/understanding-parkinsons/webinar-registration.php?id=37&e=1623818&k=32A45B9968329E31525CDD93A2EB2B48&et_cid=1054056&et_rid=225051453&et_lid=Third+Thursday+Webinarem_cid=

Drug Reverses ‘Off’ Periods in Phase III Trial

post

People with Parkinson’s disease (PD) who experience “off” periods, times when symptoms return because medication isn’t working optimally, soon may have a new treatment option.

For more information click here:

http://news.sunovion.com/press-release/sunovion-announces-positive-topline-results-pivotal-study-apomorphine-sublingual-film

and here:

https://www.michaeljfox.org/foundation/news-detail.php?drug-reverses-off-periods-in-phase-iii-trial&et_cid=1052404&et_rid=225051453&et_lid=FoxFlashem_cid=

$24-Million Public-Private Partnership to Expand Investigation

post

The Michael J. Fox Foundation (MJFF), the National Institutes of Health (NIH) and five life sciences companies  announced a public-private partnership to advance understanding, measurement and treatment of Parkinson’s disease. The latest focus of the NIH Accelerating Medicines Partnership (AMP) model, this new AMP PD project will apply cutting-edge technologies to tease apart microscopic differences in the cells of people with Parkinson’s disease (PD).

To know more:

https://www.nih.gov/news-events/news-releases/nih-launches-partnership-improve-success-clinical-trials-patients-parkinsons-disease